Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
SUMMIT THERAPEUTICS INC
About SMMT
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician, caregiver and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. Its lead development candidate is ivonescimab, a novel, potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. Ivonescimab is being developed by both Akeso and the Company in multiple Phase III clinical trials. It is also developing ivonescimab in non-small cell lung cancer and other solid tumor settings. Ivonescimab is approved in China in combination with chemotherapy for patients with EGFR-mutated non-small cell lung cancer whose tumors have progressed following an EGFR-TKI based on the results of the HARMONi-A clinical trial.
Find out what a historical investment in SUMMIT THERAPEUTICS INC would be worth today using our SMMT stock calculator.
Market Capitalisation
$12.30B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
4.62M
High today
$17.93
Low today
$16.13
Open price
$16.13
52-week high
$30.98
52-week low
$13.83
Ready to start your investing journey with Stake?
Open an accountHow do I buy SMMT shares in Australia?
Buying SMMT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in SUMMIT THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SMMT
What is the ticker symbol of SUMMIT THERAPEUTICS INC?
The ticker symbol for SUMMIT THERAPEUTICS INC is SMMT.
How much is one share of SMMT?
One share of SMMT is valued at $17.80 as of 20 May 2026.
What is the market capitalisation of SUMMIT THERAPEUTICS INC SMMT?
As of 20 May 2026 SUMMIT THERAPEUTICS INC has a market cap of $12.30B.
What is the 52-week high for SUMMIT THERAPEUTICS INC stock?
The SUMMIT THERAPEUTICS INC 52-week high stock price is $30.98.
What is the 52-week low for SUMMIT THERAPEUTICS INC stock?
The SUMMIT THERAPEUTICS INC 52-week low stock price is $13.83.
Can I buy SMMT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SMMT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SMMT on Stake
- Buy SMMT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SMMT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SMMT related stocks